Summary:
This will be a multi-center, randomized, placebo controlled parallel-group study to replicate efficacy of Nebulized Fluticasone Propionate (FP) in adult subjects with partly controlled and uncontrolled asthma. Individual participation will be approximately 16 weeks, including 12 weeks of double-blind treatment.
Qualified Participants Must:
• Be between the ages of 18-60
•
Have been diagnosed and have clinical history of Asthma that is sometimes difficult to control
•
Have continually been treated with inhaled corticosteroids
•
Be a non-smoker or smoke free for at least a year
Qualified Participants May Receive:
Study related medical care and compensated for time and travel if you qualify.